CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
27 hedge funds and large institutions have $12.7M invested in Cymabay Therapeutics in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Holders
27
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$33K | |
| 2 | +$32K | |
| 3 | +$22K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.76K |
| 5 |
Morgan Stanley
New York
|
+$2.36K |
Top Sellers
| 1 | -$591K | |
| 2 | -$425K | |
| 3 | -$52K | |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$50.9K |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$47.1K |